Figure 1 provides a visual summary of the molecular mechanisms by which inflammation, oxidative stress, and dysregulation of the NOS/eNOS pathway contribute to ED and the increased cardiovascular risk observed in RA. This evidence concerns the gene NOS3 and rheumatoid arthritis.